E133 844
The
Platinum
Hall of Fame
J. Fütterer, S. Bouwense, I. van Oort, F. Schröder, H. Huisman,
J. Barentsz
European Urology 2012;61:177–184
&
Immunocytology Is a Strong Predictor of Bladder
Cancer Presence in Patients With Painless Hematuria:
A Multicentre Study
E.K. Cha, L.-A. Tirsar, C. Schwentner, P.J. Christos, C. Mian,
J. Hennenlotter, T. Martini, A. Stenzl, A. Pycha, S.F. Shariat,
B.J. Schmitz-Dräger
European Urology 2012;61:185–192
2014
Prostate-specific Antigen (PSA) Testing Is Prevalent and
Increasing in Stockholm County, Sweden, Despite No
Recommendations for PSA Screening: Results from a
Population-based Study, 2003–2011
T. Nordström, M. Aly, M.S. Clements, C.E. Weibull, J. Adolfsson,
H. Grönberg
European Urology 2013;63:419–425
&
Metformin and Prostate Cancer: Reduced Development
of Castration-resistant Disease and Prostate Cancer
Mortality
D.E. Spratt, C. Zhang, Z.S. Zumsteg, X. Pei, Z. Zhang, M.J. Zelefsky
European Urology 2013;63:709–716
2015
Propensity-Matched Comparison of Morbidity and
Costs of Open and Robot-Assisted Radical Cystectomies:
A Contemporary Population-Based Analysis in the
United States
J.J. Leow, S.W. Reese, W. Jiang, S.R. Lipsitz, J. Bellmunt, Q.-D. Trinh,
B.I. Chung, A.S. Kibel, Steven L. Chang
European Urology 2014;66:569–576
&
Survival Outcome and Treatment Response of Patients
with Late Relapse from Renal Cell Carcinoma in the
Era of Targeted Therapy
N. Kroeger, T.K. Choueiri, J.-L. Lee, G.A. Bjarnason, J.J. Knox,
M.J. MacKenzie, L. Wood, S. Srinivas, U.N. Vaishamayan,
S.-Y. Rha, S.K. Pal, T. Yuasa, F. Donskov, N. Agarwal, M.-H. Tan,
A. Bamias, C.K. Kollmannsberger, S.A. North, B.I. Rini, D.Y.C. Heng
European Urology 2014;65:1086–1092
2016
Efficacy of enzalutamide following abiraterone acetate
in chemotherapy-naive metastatic castration-resistant
prostate cancer patients
A.A. Azad, B.J. Eigl, R.N. Murray, C. Kollmannsberger, K.N. Chi
European Urology 2015;67:23–29
&
Preoperative Prostate-specific Antigen Isoform p2PSA
and Its Derivatives, %p2PSA and Prostate Health Index,
Predict Pathologic Outcomes in Patients Undergoing
Radical Prostatectomy for Prostate Cancer: Results
from a Multicentric European Prospective Study
N. Fossati, N.M. Buffi, A. Haese, C. Stephan, A. Larcher,
T. McNicholas, A. de la Taille, M. Freschi, G. Lughezzani, A. Abrate,
V. Bini, J. Palou Redorta, M. Graefen, G. Guazzoni, M. Lazzeri
European Urology 2015;68:132–138
2017
Renal Cell Carcinoma Programmed Death-ligand 1, a
New Direct Target of Hypoxia-inducible Factor-2 Alpha,
is Regulated by von Hippel–Lindau Gene Mutation Status
Y. Messai, S. Gad, M.Z. Noman, G. Le Teuff, S. Couve, B. Janji,
S.F. Kammerer, N. Rioux-Leclerc, M. Hasmim, S. Ferlicot, V. Baud,
A. Mejean, D.R. Mole, S. Richard, A.M.M. Eggermont, L. Albiges,
F. Mami-Chouaib, B. Escudier, S. Chouaib
European Urology 2016;70:623–632
&
Results of a Randomised Controlled Trial Comparing
Intravesical Chemohyperthermia with Mitomycin C
Versus Bacillus Calmette-Guérin for Adjuvant Treatment
of Patients with Intermediate- and High-risk Non–Muscle-
invasive Bladder Cancer
T.J.H. Arends, O. Nativ, M. Maffezzini, O. de Cobelli, G. Canepa,
F. Verweij, B. Moskovitz, A.G. van der Heijden, J.A. Witjes
European Urology 2016;69:1046–1052
Best Paper in Robotic Surgery
2016
Pilot Validation Study of the European Association of
Urology Robotic Training Curriculum
A. Volpe, K. Ahmed, P. Dasgupta, V. Ficarra, G. Novara, H. van der Poel,
A. Mottrie
European Urology 2015;68:292–299
2017
Measuring to Improve: Peer and Crowd-sourced
Assessments of Technical Skill with Robot-assisted
Radical Prostatectomy
K.R. Ghani, D.C. Miller, S. Linsell, A. Brachulis, B. Lane, R. Sarle,
D. Dalela, M. Menon, B. Comstock, T.S. Lendvay, J. Montie, J.O. Peabody,
for the Michigan Urological Surgery Improvement Collaborative
European Urology 2016;69:547–550